Active substances
Amlodipine + Indapamide + Perindopril
- SFDA 8
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Pratima Trio | 10,10,2.5 mg,mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 150.40 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| Pratima Trio | 10,2.5,5 mg,mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 138.65 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| Pratima Trio | 5,1.25,5 mg,mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 83.20 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| Pratima Trio | 5,1.25,10 mg,mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 94.95 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| Triplixam | 5,1.25,5 mg,mg,mg | Film-coated tablet · Oral use | 30 Bottle | SAR 83.20 | NCE · Prescription | LES LABORATOIRES SERVIER | Valid |
| Triplixam | 10,2.5,5 mg,mg,mg | Film-coated tablet · Oral use | 30 Bottle | SAR 133.30 | NCE · Prescription | LES LABORATOIRES SERVIER | Valid |
| Triplixam | 5,1.25,10 mg,mg,mg | Film-coated tablet · Oral use | 30 Bottle | SAR 94.95 | NCE · Prescription | LES LABORATOIRES SERVIER | Valid |
| Triplixam | 10,2.5,10 mg,mg,mg | Film-coated tablet · Oral use | 30 Bottle | SAR 133.30 | NCE · Prescription | LES LABORATOIRES SERVIER | Valid |
Indications — CHI Daman Drug Formulary
HYPERTENSION
WHO WHO Model List of Essential Medicines (2025)
- 12.3. Antihypertensive medicines · core
Essential hypertension
Oral > Solid > dosage form: 5 mg (arginine) + 5 mg + 1.25 mg; 5 mg (arginine) + 10 mg + 1.25 mg; 10 mg (arginine) + 5 mg + 2.5 mg; 10 mg (arginine) + 10 mg + 2.5 mg
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.